These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7437816)

  • 1. The drug industry. The public image.
    Smith T
    Br Med J; 1980 Nov; 281(6252):1410-1. PubMed ID: 7437816
    [No Abstract]   [Full Text] [Related]  

  • 2. New image for the drug industry.
    Cohen D
    BMJ; 2011 Nov; 343():d7713. PubMed ID: 22127772
    [No Abstract]   [Full Text] [Related]  

  • 3. Attitudes of physicians and public to pharmaceutical industry 'gifts'.
    Macneill PU; Kerridge IH; Newby D; Stokes BJ; Doran E; Henry DA
    Intern Med J; 2010 May; 40(5):335-41. PubMed ID: 20345507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is the pharmaceutical industry really as bad as its reputation?].
    Prat EH
    Wien Med Wochenschr; 2005 Nov; 155(21-22):502-12. PubMed ID: 16425111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should the drug industry work with key opinion leaders? Yes.
    Buckwell C
    BMJ; 2008 Jun; 336(7658):1404. PubMed ID: 18566075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disease-mongers].
    Westin S
    Tidsskr Nor Laegeforen; 2002 Jun; 122(17):1638. PubMed ID: 12555601
    [No Abstract]   [Full Text] [Related]  

  • 7. PUBLIC attitudes toward prescription costs and the drug industry. Part III. Public attitudes toward the drug manufacturers.
    SD J Med Pharm; 1960 Sep; 13():486-91. PubMed ID: 13858299
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical research in the world setting.
    Williams PO
    Proc R Soc Med; 1970 Nov; 63(11 Part 2):1201-7. PubMed ID: 5485503
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulating the pharmaceutical industry. General public does not support value system inherent in cost effectiveness analyses.
    Furniss J; Zammit-Lucia J; Johnson N
    BMJ; 1998 Jan; 316(7126):226; author reply 228. PubMed ID: 9468699
    [No Abstract]   [Full Text] [Related]  

  • 10. Democracy unleashed--unpacking the tooth fairy in drug industry R&D.
    Ozdemir V; Williams-Jones B
    Nat Biotechnol; 2006 Nov; 24(11):1324-6; author reply 1326-7. PubMed ID: 17093467
    [No Abstract]   [Full Text] [Related]  

  • 11. Restoring confidence in the pharmaceutical industry.
    Bauchner H; Fontanarosa PB
    JAMA; 2013 Feb; 309(6):607-9. PubMed ID: 23403686
    [No Abstract]   [Full Text] [Related]  

  • 12. Wisdom of the crowd.
    Nature; 2005 Nov; 438(7066):281. PubMed ID: 16292279
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceuticals, patents, publicity...and philanthropy?
    Lancet; 2009 Feb; 373(9665):693. PubMed ID: 19249610
    [No Abstract]   [Full Text] [Related]  

  • 14. Problematic Jumps in Drug Prices and What You Can Do.
    Shaughnessy AF
    Am Fam Physician; 2017 Jul; 96(1):16-18. PubMed ID: 28671371
    [No Abstract]   [Full Text] [Related]  

  • 15. Bitter pills.
    Carpenter D
    Hosp Health Netw; 2000 Aug; 74(8):48-52. PubMed ID: 10983224
    [No Abstract]   [Full Text] [Related]  

  • 16. Bribes for doctors: a gift for bioethicists?
    Mansfield PR
    Am J Bioeth; 2003; 3(3):47-8. PubMed ID: 14594490
    [No Abstract]   [Full Text] [Related]  

  • 17. Public backs federal control of doctors' fees.
    Med World News; 1980 Jan; 21(1):9-10. PubMed ID: 10245024
    [No Abstract]   [Full Text] [Related]  

  • 18. Doctors in India demand stricter rules over drug industry gifts.
    Dutta SS
    BMJ; 2017 Aug; 358():j3812. PubMed ID: 28790047
    [No Abstract]   [Full Text] [Related]  

  • 19. A gift to pharma?
    Nat Med; 2005 Jul; 11(7):693. PubMed ID: 16015340
    [No Abstract]   [Full Text] [Related]  

  • 20. DTC ads in US having huge impact on drug sales.
    Korcok M
    CMAJ; 2002 Aug; 167(3):289. PubMed ID: 12186182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.